JP2025502242A5 - - Google Patents
Info
- Publication number
- JP2025502242A5 JP2025502242A5 JP2024541925A JP2024541925A JP2025502242A5 JP 2025502242 A5 JP2025502242 A5 JP 2025502242A5 JP 2024541925 A JP2024541925 A JP 2024541925A JP 2024541925 A JP2024541925 A JP 2024541925A JP 2025502242 A5 JP2025502242 A5 JP 2025502242A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- administered
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2022/013586 | 2022-01-25 | ||
| US2022013586 | 2022-01-25 | ||
| PCT/US2023/061202 WO2023147318A2 (en) | 2022-01-25 | 2023-01-25 | Aqueous cevimeline compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502242A JP2025502242A (ja) | 2025-01-24 |
| JP2025502242A5 true JP2025502242A5 (enExample) | 2026-02-02 |
Family
ID=87472506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541925A Pending JP2025502242A (ja) | 2022-01-25 | 2023-01-25 | 水性セビメリン組成物および使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4469047A4 (enExample) |
| JP (1) | JP2025502242A (enExample) |
| TW (1) | TWI916635B (enExample) |
| WO (1) | WO2023147318A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO2024016594A1 (es) * | 2024-12-02 | 2024-12-09 | Espec Oftalmologicas S A | Colirio oftalmológico y/o vehículo farmacéutico indicado para el restablecimiento y la protección de la histéresis de la película lagrimal |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2752008T3 (es) * | 2009-10-30 | 2020-04-02 | Intratus Inc | Métodos y composiciones para la liberación sostenida de fármacos |
| US10307408B2 (en) | 2013-08-28 | 2019-06-04 | Presbyopia Therapies, LLC | Contact lens compositions and methods for the treatment of presbyopia |
| IL265791B (en) | 2016-10-04 | 2022-07-01 | Cellix Bio Private Ltd | Compositions and methods for the treatment of xerostomia |
| EP3749303A4 (en) * | 2018-02-05 | 2022-01-26 | Cellixbio Private Limited | COMBINATION OF AN ANTIMUSCARINE OR ANTICCHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF |
| US20210369686A1 (en) | 2018-10-06 | 2021-12-02 | Biotheravision Llc | Ophthalmic preparations of muscarinic agonist and methods of use |
| BR112021006618B1 (pt) * | 2018-10-10 | 2022-09-27 | Presbyopia Therapies, Inc | Composições e métodos para o tratamento da presbiopia |
-
2023
- 2023-01-16 TW TW112101732A patent/TWI916635B/zh active
- 2023-01-25 JP JP2024541925A patent/JP2025502242A/ja active Pending
- 2023-01-25 EP EP23747794.8A patent/EP4469047A4/en active Pending
- 2023-01-25 WO PCT/US2023/061202 patent/WO2023147318A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4860475B2 (ja) | ２種のポリマーの相乗作用的組み合わせを含む眼科用組成物 | |
| JP2025142338A5 (enExample) | ||
| JP5161950B2 (ja) | ３種のポリマーの相乗作用的組み合わせを含む眼科用組成物 | |
| JP2020196718A5 (enExample) | ||
| JP2006516032A5 (enExample) | ||
| JP2011006448A (ja) | 第四級化アンモニウムシクロデキストリン化合物 | |
| JP2007500244A5 (enExample) | ||
| JP5571673B2 (ja) | 粘液様の組成物およびその使用 | |
| JP2000515543A (ja) | ヘルペスウイルスにより起こる感染を予防または治療するためのキトサンと組み合わされたヘパリンまたはヘパラン硫酸の使用 | |
| JP6683622B2 (ja) | 眼科用水性組成物 | |
| JPH05213757A (ja) | 水性液剤 | |
| JP2019142974A5 (enExample) | ||
| CN110869023A (zh) | 原位凝胶形成药物组合物及其在鼻窦疾病中的应用 | |
| JP2019104727A (ja) | 水溶性高分子を含む水性液剤 | |
| WO2015176655A1 (zh) | 一种阿利沙坦酯固体分散体及药物组合物 | |
| US20070049552A1 (en) | Fluoroquinolone formulations and methods of making and using the same | |
| KR102872122B1 (ko) | 다회-사용 토라세미드 조성물 | |
| CA3196559A1 (en) | Ophthalmic composition | |
| WO2014135123A1 (zh) | 17α-乙炔基雄甾-5-烯-3β, 7β, 17β-三醇眼用制剂 | |
| CN103142461A (zh) | 一种阴道用凝胶剂及其制备方法 | |
| CA3169401A1 (en) | Xanthan-based ophthalmic topical formulations with a reduced dosage regimen | |
| CN102497854A (zh) | 含有作为防腐剂的丙酸衍生物的眼用液体药物组合物 | |
| TR2022007382A2 (tr) | Nonsteroi̇dal anti̇enflamatuvar etken madde i̇çeren göz damlasi bi̇leşi̇mi̇ | |
| KR102268319B1 (ko) | 지속성 점안제 조성물 | |
| WO2025018419A1 (ja) | 水性液剤 |